Please select one:

Healthcare professional (HCP) illustration.

For healthcare providers

Family illustration

For people living with an IRD

EYES ON A BRIGHTER FUTURE: EMERGING IRD TREATMENTS

Ramya, living with an IRD

Ramya, a woman living with an inherited retinal disease (IRD), smiling at the camera

Gene therapy is an exciting treatment advance that changes a specific part of a person’s genes to treat disease. The first gene therapy for an inherited retinal disease (IRD) was approved by the FDA in 2017.* Today there are more than 40 ongoing clinical trials to find a solution for people living with IRD.

Timeline of gene therapy and its development from 1990-2024Timeline of gene therapy and its development from 1990-2024

After receiving your results, your genetic counselor and eye specialist may recommend extra steps to find out if you are eligible for a clinical trial or for approved or emerging therapies.

Learn more about ongoing trials here

Types of gene therapy

Many gene therapy innovations are now being studied. Each therapy (below) is designed to affect genes associated with inherited retinal disease in a special way.

Normal copy of mutated gene inserted into the host cells through gene replacement therapy (augmentation therapy)

Gene replacement therapy

Gene replacement therapy, also known as augmentation therapy, works by inserting normal copies of the mutated gene into the host cells

Gene variant corrected within the host DNA through gene editing, a type of gene therapy

Gene editing

Gene editing corrects the gene variant directly within the host DNA

Ribonucleic acid (RNA) being altered through RNA editing, a type of gene therapy

RNA editing

RNA (ribonucleic acid) editing edits the RNA, not the DNA

The eye is an ideal focus for gene therapy.
Here’s why:

  • Treatment can be delivered directly to the eye with a one-time outpatient procedure
  • Results are easy to observe, making it a relatively easier method for an eye specialist to track your progress
  • Any side effects that might happen tend to be localized to the eye and systemic side effects are limited
Healthcare professional (HCP) illustration

See what’s possible when you test or retest.

It is important to share the facts on gene therapy

40 icon

More than 40 clinical trials have been completed or are underway for different types of IRDs. Gene therapy exists for many other genetic conditions as well.

Lab tubes icon

There are already US FDA- and EMA-approved gene therapies on the market, including one for IRDs.

Genetic Testing Results 101 checklist illustration

There are gene therapies that only change DNA in the cells of the body, called somatic cells, which are not passed along to your children.